Skip to main content
Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · IEX Real-Time Price · USD
4.720
-0.160 (-3.28%)
At close: May 17, 2024, 4:00 PM
4.630
-0.090 (-1.91%)
After-hours: May 17, 2024, 4:07 PM EDT

Werewolf Therapeutics Revenue

Werewolf Therapeutics had revenue of $16.22M in the twelve months ending March 31, 2024, down -22.26% year-over-year. Revenue in the quarter ending March 31, 2024 was $742.00K, a -83.38% decrease year-over-year. In the year 2023, Werewolf Therapeutics had annual revenue of $19.94M with 21.60% growth.

Revenue (ttm)
$16.22M
Revenue Growth
-22.26%
P/S Ratio
12.83
Revenue / Employee
$345,128
Employees
47
Market Cap
208.15M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202319.94M3.54M21.60%
Dec 31, 202216.40M--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Inogen 321.52M
AVITA Medical 51.50M
Cellectis 9.19M
Lineage Cell Therapeutics 8.00M
Profound Medical 5.33M
Delcath Systems 4.61M
INmune Bio 131.00K
Revenue Rankings

HOWL News

More News